Department of Psychiatry

Publications

Division of Substance Dependence
Published Works Since the Creation of the Division in 1999

Currently Submitted:
Crowley TJ, Young SE, Raymond KM, Mikulich-Gilbertson SK, Rhea SA. (submitted). Multi-year stability of abuse-neglect self-reports: Adolescents with serious conduct and substance problems.

Ehringer MA, Zeiger JS, Haberstick BC, Schlaepfer I, Collins AC, Corley RP, Crowley TJ, Hewitt JK, Hopfer CJ, Lessem J, McQueen MB, Rhee SH. (2007, submitted). The neuronal nicotinic receptor subunit genes (CHRNA6 and CHRNB3) are associated with subjective responses to tobacco.

Gelhorn H, Sakai J, Mikulich-Gilbertson S, Stallings M, Young S, Corley R, Rhee SH, Hopfer C, Hewitt J, Crowley T. (submitted). Categorical and continuous measurement of adolescent antisocial behavior using DSM-IV conduct disorder symptom criteria.

Mikulich-Gilbertson SK (submitted). Using the Delta Method to compare nonlinear parameters from cosinor analyses among groups.

Milham MP, Crowley TJ, Thompson LL, Raymond KM, Claus ED, Banich MT. (submitted). Reduction in orbitofrontal brain volume in adolescents with severe substance and conduct problems.

Schlaepfer I, Collins AC, Corley RP, Crowley TJ, Hewitt JK, Hopfer CJ, Krauter K, Lessem J, McQueen MB, Rhee SH, Smolen A, Stallings MC, Young SE, Ehringer MA. (submitted) The CHRNA5/A3/B4 gene cluster variability as an important determinant of alcohol and tobacco initiation in young adults.

Timberlake DS, Haberstick BC, Gelhorn H, Sakai JT, Hopfer C, Lessem JM, Hewitt JK. (submitted). Correlates of methamphetamine use in a nationally representative sample of young adults.

Currently In Press:
Booth RE, Lehman WE, Brewster JT, Sinitsyana L, Dvoryak S. (2007). Gender differences in sex risk behaviors among Ukraine injection drug users. Journal of the Acquired Immune Deficiency Syndromes.

Corsi KF, Kwiatkowski CF, Booth RE. (in press). Predictors of methamphetamine injection in out-of-treatment IDUs. Substance Use and Misuse.

Corsi KF, Rinehart DJ, Kwiatkowski CF, Booth RE. (in press). Case management outcomes for women who use crack. Journal of Evidence-Based Social Work.

Corsi KF, Winch PJ, Kwiatkowski CF, Booth RE. (in press). Childhood factors that precede drug injection: is there a link? Journal of Child and Family Studies.

Gelhorn HL, Sakai JT, Price RK, Crowley TJ. (in press). DSM-IV Conduct disorder criteria as predictors of antisocial personality disorder. Comprehensive Psychiatry.

Hartman CA, Gelhorn H, Crowley TJ, Sakai J, Stallings MC, Young SE, Corley R, Hewitt JK, Hopfer CJ. (in press). An Item Response Theory analysis of DSM-IV marijuana abuse and dependence criteria in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry.

Hopfer CJ, Riggs PD. (in press) Chapter 52 “Substance Abuse Disorders.” Lewis’s Child and Adolescent Psychiatry: A Comprehensive Textbook, Fourth Edition.

Libby A, Riggs PD. (in press) Integrated substance use and mental health services for adolescents: Challenges and opportunities, Chapter 17. In: Y. Kaminer, O. Bukstein (Eds.), Adolescent Substance Abuse: Psychiatric Comorbidity and High Risk Behaviors. New York NY: Haworth Press.

Plomondon ME, Ho PM, Wang L, Greiner GT, Shore JH, Sakai JT, Fihn SD, Rumsfeld JS. (in press). Severe mental illness and mortality of hospitalized acute coronary syndrome patients in the veterans healthcare administration. BMC Health Services Research

Riggs PD, Thompson L, Tapert S, Frascella J, Mikulich-Gilbertson S, Dalwani M, Laudenslager M, Lohman M. (in press). Advances in neurobiological research related to interventions in adolescents with substance use disorders: Research to practice. Drug and Alcohol Dependence.

Sakai JT, Risk NK, Tanaka CA, Price RK. (in press). Asians in the U.S. conduct disorder and antisocial personality disorder: associated factors and commonly comorbid problems. Psychological Medicine.

Salomonsen-Sautel S, Malberg D, Gilroy C, Boyle S, Van Leeuwen JM, Hopfer CH. (in press). Correlates of substance use among homeless youth in eight cities.

Schulz-Heik RJ, Maentz SK, Rhee SH, Gelhorn HL, Young SE, Stallings MC, Timberlake D, Smolen A, Stetler GL, Sakai JT, Crowley TJ. (in press). Case-control and within-family tests for an association between conduct disorder and DAT1. Psychiatric Genetics.

Sorensen JL, Brown L, Calsyn D, Tross S, Booth RE, Song Y, Normand J. (in press). AIDS research in the NIDA clinical trials network: emerging results. Drug and Alcohol Dependence.

Tanabe J, Crowley T, Hutchison K, Miller D, Johnson G, Du YP, Zerbe G, Freedman R. (2007, in press) Ventral striatal blood flow is altered by acute nicotine but not withdrawal from nicotine. Neuropsychopharmacology.

Thurstone C, Riggs PD, Klein C, Mikulich-Gilbertson SK. (in press). A one-session human immunodeficiency virus risk-reduction intervention in adolescents with psychiatric and substance use disorders. Journal of the American Academy of Child and AdolescentPsychiatry.

Published:
2007
Anderson KG, Tapert SF, Moadab I, Crowley TJ, Brown SA. (2007). Personality risk profile for conduct disorder and substance use disorders in youth. Addictive Behaviors, 32: 2377-2382.

Banich, M.T., Crowley, T.J., Thompson, L.L., Jacobson, B.J., Liu, X., Raymond, K.M., Claus, E.D. (2007). Brain activation during the Stroop task in adolescents with severe substance and conduct problems: A pilot study. Drug and Alcohol Dependence, 90, 175-182.

Corsi KF, Kwiatkowski CF, Booth RE. (2007). Treatment entry and predictors among opiate-using injection drug users. The American Journal of Drug and Alcohol Abuse, 33(1): 121-127.

Crowley TJ. (2007). Adolescents and substance related disorders: Research agenda to guide decisions in DSM-V, in Diagnostic Issues in Substance Use Disorders: Refining the Research Agenda for DSM-V. eds. Saunders, J.B., Schuckit M.A., Sirovatka, P.J., Regier, D.A. pages 203-220.

Davies RD, Riggs PD (2007). Integrated treatment of substance use disorders and co-occurring psychiatric disorders in adolescents. In: Gilvarry E, McArdle P (eds). Alcohol, Drugs, and Young People: Clinical Approaches. MacKeith Press.

Ehringer MA, Clegg HV, Collins AC, Corley RP, Crowley TJ, Hewitt JK, Hopfer CJ, Krauter K, Lessem J, Rhee SH, Schlaepfer I, Smolen A, Stallings MC, Young SE, Zeiger JS. (2007). Association of the neuronal nicotinic receptor b2 subunit gene (CHRNB2) with subjective responses to alcohol and nicotine. American Journal of Medical Genetics – Neuropsychiatric Genetics, 144B, 596-604.

Haberstick BC, Timberlake D, Ehringer MA, Lessem JM, Hopfer CJ, Smolen A, Hewitt JK. (2007). Genes, time to first cigarette and nicotine dependence in a general population sample of young adults. Addiction, 102, 655-665.

Haberstick BC, Timberlake D, Smolen A, Sakai JT, Hopfer CJ, Corley RP, Young SE, Stallings MC, Huizinga D, Menard S, Hartman C, Grotpeter J, Hewitt JK. (2007). Between and within-family association test of the dopamine receptor D2 TaqIA polymorphism and alcohol abuse and dependence in a general population sample of adults. Journal of Studies on Alcohol and Drugs, 69, 362-370.

Hopfer CJ, Lessem JM, Hartman CA, Stallings MC, Cherny SS, Corley RP, Hewitt JK, Krauter KS, Mikulich-Gilbertson SK, Rhee SH, Smolen A, Young SE, Crowley TJ. (2007). A genome-wide scan for loci influencing adolescent cannabis dependence symptoms: Evidence for linkage on chromosomes 3 and 9. Drug and Alcohol Dependence, 89: 34-41.

Mikulich-Gilbertson SK, Salomonsen-Sautel S, Sakai JT, Booth RE. (2007). Gender similarities and differences in antisocial behavioral syndromes among injection drug users. American Journal on Addictions, 16: 372-382.

Riggs PD. (2007). A 15-Year Old Boy With Failing Grades and "Sneaky" Behavior. Medscape Case Sponsored by Shire Pharmaceutical unrestricted educational grant.

Riggs PD, Mikulich-Gilbertson, SK, Davies RD, Lohman M, Klein C, Stover SK. (2007). A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders Archives of Pediatric and Adolescent Medicine, 161(11): 1-9.

Schlaepfer I, Clegg HV, Corley RP, Crowley T, Hewitt JK, Hopfer CJ, Krauter K, Lessem J, Rhee SH, Stallings MC, Wehner JM, Young SE, Ehringer MA. (2007). The human protein kinase C-gamma gene (PRKCG) as a susceptibility locus for hyperactive/impulsive behaviors. Addiction Biology, 12, 200-209.

Sakai JT, Hopfer CJ, Hartman C, Haberstick BC, Smolen A, Corley RP, Stallings MC, Young SE, Timberlake D, Hewitt JK, Crowley TJ. (2007). Test of association between TaqIA A1 allele and alcohol use disorder phenotypes in a sample of adolescent patients with serious substance and behavioral problems. Drug and Alcohol Dependence, 88, 130-137.

Sakai, JT, Lessem JM, Haberstick BC, Hopfer CJ, Smolen A, Ehringer MA, Timberlake D, Hewitt JK. (2007). Case-control and with-in family tests for association between 5HTTLPR and conduct problems in a longitudinal adolescent sample. Psychiatric Genetics, 14, 207-214.

Timberlake DS, Haberstick BC, Hopfer CJ, Bricker J, Sakai JT, Lessem JM, Hewitt JK. (2007). Progression from marijuana use to daily smoking and nicotine dependence in a national sample of U.S. adolescents. Drug and Alcohol Dependence, 88, 272-281.

2006
Booth RE, Kwiatkowski CF, Brewster JT, Sinitsyna L, Dvoryak S. (2006). Predictors of HIV sero-status among drug injectors at three Ukraine sites. AIDS, 20: 2217-2223.

Booth RE, Kwiatkowski CF, Mikulich-Gilbertson, Brewster JT, Salomonsen-Sautel S, Corsi KF, Sinitsyna L. (2006). Predictors of risky needle use following interventions with drug injectors in Ukraine. Drug and Alcohol Dependence, 82S1: S49-57.

Carroll KM, Ball SA, Nich C, Martino S, Frankforter TL, Farentinos C, Kunkel LE, Mikulich-Gilbertson SK, Morgenstern J, Obert JL, Polcin D, Snead N, Woody GE. (2006). Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: A multisite effectiveness study. Drug and Alcohol Dependence, 81: 301-312.

Corsi KF, Kwiatkowski CF, Booth RE. (2006). Long-term predictors of HIV risk behaviors among IDUs. Journal of Drug Issues. 36(3): 649-666.

Corsi KF, Van Hunnik B, Kwiatkowski CF, Booth RE. (2006). Computerized Tracking and Follow-up Techniques in Longitudinal Research with Drug Users. Health Services and Outcomes Research Methodology, 6: 101-110.

Crowley TJ. (2006). Adolescents and substance related disorders: Research agenda to guide decisions in DSM-V. Addictions, 101(S1): 115-124.

Crowley TJ, Raymond KM, Mikulich-Gilbertson SK, Thompson LL, Lejuez CW. (2006). A risk-taking “set” in a novel task among adolescents with serious conduct and substance problems. Journal of the American Academy of Child and Adolescent Psychiatry, 45: 175-183.

Drell MJ, Josephson A, Pleak R, Riggs P, Rosenfeld A. (2006). Clinical problem solving: The case of John, Part II: Excerpts from sessions 2-7. Journal of the American Academy of Child and Adolescent Psychiatry, 45(10): 1243-1251.

Gelhorn HL, Stallings MC, Young SE, Corley RP, Rhee SH, Hopfer CH, Hewitt JK. (2006). Common and specific genetic influences on aggressive and non-aggressive conduct disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 45: 570-577.

Hartman CA, Lessem JM, Hopfer CJ, Crowley TJ, Stallings MC. (2006). The family transmission of adolescent alcohol abuse and dependence. Journal of Studies on Alcohol, 67: 657-664.

Hopfer CJ, Mendelson B, Van Leeuwen JM, Kelly S, Hooks S, Petersen J. (2006). Club drug use among youth in treatment for substance abuse and homeless/runaway youth. American Journal on Addictions, 15: 94-99.

Hopfer CJ, Young SE, Purcell S, Crowley TJ, Stallings MC, Corley RP, Rhee SH, Smolen A, Krauter K, Hewitt JK, Ehringer MA. (2006). Cannabis receptor haplotype associated with fewer cannabis dependence symptoms in adolescents. American Journal of Medical Genetics – Neuropsychiatric Genetics, 141B: 895-901.

Lessem JM, Hopfer CJ, Haberstick BC, Timberlake DS, Ehringer MA, Smolen A, Hewitt JK. (2006). Relationship between adolescent marijuana use and young adult illicit drug use. Behavior Genetics, 36: 498-506.

Mikulich-Gilbertson SK, Morgenstern J, Obert JL, Polcin D, Snead N, Woody GE. (2006). Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: A multisite effectiveness study. Drug and Alcohol Dependence, 81: 301-312.

Rhee SH, Hewitt JK, Young SE, Corley RP, Crowley TJ, Neale MC, Stallings MC. (2006). Comorbidity between alcohol dependence and illicit drug dependence in adolescents with antisocial behavior and matched controls. Drug and Alcohol Dependence, 84: 85-92.

Sakai JT, Mikulich-Gilbertson SK, Crowley TJ. (2006). Adolescent inhalant use among male patients in treatment for substance and behavior problems: Two-year outcome. American Journal of Drug and Alcohol Abuse, 32: 29-40.

Sakai JT, Mikulich-Gilbertson SK, Long RJ, Crowley TJ. (2006) Validity of transdermal alcohol monitoring: Fixed and self-regulated dosing. Alcoholism: Clinical and Experimental Research, 30: 26-33.

Sakai JT, Young SE, Stallings MC, Timberlake D, Smolen A, Stetler GL, Crowley TJ. (2006). Case-control and within-family tests for an association between conduct disorder and 5HTT-LPR. American Journal of Medical Genetics – Neuropsychiatric Genetics, 141B: 825-832.

Thompson LL, Whitmore EA, Raymond KM, Crowley TJ. (2006). Measuring impulsivity in adolescents with serious substance and conduct problems. Psychological Assessment, 13: 3-15.

Timberlake DS, Haberstick BC, Hopfer CJ, Lessem JM, Smolen A, Ehringer MA, Hewitt JK. (2006). An association between the DAT1 polymorphism and smoking behavior in young adults from the National Longitudinal Study of Adolescent Health. Health Psychology, 25: 190-197.

Timberlake DS, Rhee SH, Haberstick BC, Hopfer CJ, Ehringer MA, Lessem JM, Smolen A, Hewitt JK. (2006). The moderating effects of religiosity on the genetic and environmental determinants of smoking initiation. Nicotine and Tobacco Research, 8: 123-133.

Van Leeuwen JM, Boyle S, Salomonsen-Sautel S, Baker DN, Garcia JT, Hoffman A., Hopfer CJ. (2006). Lesbian, gay, and bisexual homeless youth: An eight city public health perspective. Child Welfare, 85: 151-170.

Weissberg M, Sakai JT, Miyoshi T, Fryer GE. (2006). Medical student attitudes to risk-taking and self-perceived influence on medical practice. Medical Education, 40: 722-729.

Whitmore EA, Riggs PD. (2006). Developmentally informed diagnostic and treatment considerations in comorbid conditions. In Liddle, H.A., Rowe, C.L. (eds.) Adolescent Substance Abuse: Research and Clinical Advances. Cambridge, UK: Cambridge University Press. 264-283.

2005
Crowley TJ. (2005). Recent advances in psychosocial treatments for substance dependence: Relevance to opioid agonist maintenance treatment. In: Rihs-Middel M, Hammig R, Jacobshagen N. (eds) Heroin-assisted Treatment, Work in Progress. Pp. 167-189. Switzerland, Verlang Hans Huber.

Crowley TJ, Sakai JT. (2005). Inhalant related disorders. In: The Comprehensive Textbook of Psychiatry, 8th. pp.1247-12-57 Sadock BJ, Sadock VA (eds.) Baltimore MD, Lippincott Williams and Wilkins.

Haberstick BC, Lessem JM, Hopfer CJ, Smolen A, Ehringer MA, Timberlake D, Hewitt JK. (2005). Monoamine oxidase A (MAOA) and antisocial behaviors in the presence of childhood and adolescent maltreatment. American Journal of Medical Genetics -Neuropsychiatric Genetics, 135(1): 59-64.

Hopfer CJ, Timberlake D, Haberstick BC, Lessem JM, Ehringer MA, Smolen A, Hewitt JK. (2005). Genetic influences on quantity of alcohol consumed by adolescents and young adults. Drug and Alcohol Dependence, 78; 187 – 193.

Libby AM, Orton HD, Stover SK, Riggs PD. (2005). What came first, major depression or substance abuse disorder? clinical characteristics and substance use comparing teens in a treatment cohort. Addictive Behaviors, 30: 1649-1662.

Libby AM, Riggs PD. (2005). Integrated substance use and mental health treatment for adolescents: Aligning organizational and financial incentives. Journal of Child and Adolescent Psychopharmacology,15(5): 826-834.

Petry NM, Peirce JM, Stitzer ML, Blaine J, Roll JM, Cohen Am Obert J, Killeen T, Saladin ME, Cowell M, Kirby KC, Sterling R, Royer-Malvestuto C, Hamilton J, Booth RE, Macdonald M, Liebert M, Rader L, Burns R, DiMaria J, Copersino M, Stabile PQ, Kolodner K, Li R. (2005). Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: A national drug abuse treatment clinical trials network study. Archives of General Psychiatry, 62(10): 1148-1156.

Thompson LL. (2005). Ethical challenges in neuropsychological research, part I. In S.S. Bush (ed.), A Casebook of Ethical Challenges in Neuropsychology (pp.201-208). New York: Psychology Press.

Sakai JT, Ho PM, Shore J, Risk NK, Price RK. (2005). Asians in the U.S.: substance dependence, and use of substance dependence treatment. Journal of Substance Abuse Treatment, 29: 75-84.

Stallings MC, Corley RP, Dennehey B, Hewitt JK, Krauter KS, Lessem JM, Mikulich-Gilbertson SK, Rhee SH, Smolen A, Young SE, Crowley TJ. (2005). A genome-wide search for quantitative trait loci influencing antisocial drug dependence in adolescence. Archives of General Psychiatry, 62: 1042-1051.

2004
Benedict RHB, Cox D, Thompson LL, Foley F, Weinstock-Guttman B, Munschauer F. (2004). Reliable screening for neuropsychological impairment in multiple sclerosis. Multiple Sclerosis, 10: 675-678.

Berrettini W, Bierut L, Crowley TJ, Cubells JF, Frascella J, Gelernter J, Hewitt JK, Kreek MJ, Lachman H, Leppert M, Ling MD, Madden P, Miner C, Pollock JD, Pomerleau O, Rice JP, Rutter JL, Shurtleff D, Swan GE, Tischfield JA, Tsuang M, Uhl GR, Vanyukov M, Volkow ND, Wanke K. (2004). Setting priorities for genomic research. Science, 304: 1445-1446.

Booth RE, Corsi KF, Mikulich-Gilbertson SK. (2004). Factors associated with methadone maintenance treatment retention among street-recruited injection drug users. Drug and Alcohol Dependence, 74: 177-185.

Booth RE, Mikulich-Gilbertson SK, Brewster JT, Salomonsen-Sautel S, Semerik O. (2004). Predictors of Self-Reported HIV Infection Among Drug Injectors in Ukraine. Journal of Acquired Immune Deficiency Syndrome, 35: 82-88.

Compton WM, Horton JC, Cottler LB, Booth RE, Leukefeld CG, Singer M, Cunningham-Williams R, Reich W, Fortuin Corsi K, Staton M, Fink JL, Stopka TJ, Spitznagel EL. (2004). A Multistate trial of pharmacy syringe purchase. Journal of Urban Health,81(4): 661-670.

Crowley TJ, Sakai JT. (2004). Inhalants. In: The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 3rd. pp. 291-300 Galanter M, Kleber H (eds.) Washington DC, American Psychiatric Press.

Davies RD, Thurstone C, Woyewodzic K (2004). Substance use disorders and neurologic illness. Current Treatment Options in Neurology, 6(5): 423-432.

Helstrom A, Bryan A, Hutchison KE, Riggs PD, Blechman EA. (2004). Tobacco and alcohol use as an explanation for the association between externalizing behavior and illicit drug use among delinquent adolescents. Prev Sci, 5: 267-277.

Loo SK, Hopfer CJ, Teale PD, Reite ML. (2004). EEG Correlates of Methylphenidate Response in ADHD: Association with Cognitive and Behavioral Measures, Journal of Clinical Neurophysiology, 21: 457-464.

Riggs PD, Hall SK, Mikulich-Gilbertson SK, Lohman M, Kayser A. (2004). A randomized controlled trial of pemoline for attention deficit hyperactivity disorder in substance abusing adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 43(4): 420-429.

Sakai JT, Hall SK, Mikulich-Gilbertson SK, Crowley T.J. (2004). Inhalant use, abuse and dependence among adolescent patients: Commonly co-morbid problems. Journal of the American Academy of Child and Adolescent Psychiatry, 43(9): 1080-1088.

Sakai JT, Stallings MC, Mikulich-Gilbertson SK, Corley RP, Young SE, Hopfer CJ, Crowley TJ. (2004). Mate similarity for substance dependence and antisocial personality disorder among parents of patients and controls. Drug and Alcohol Dependence, 75(2): 165-175.

2003
Booth, RE, Corsi KF, Mikulich SK. (2003). Improving entry to methadone maintenance among out-of-treatment injection drug users. Journal of Substance Abuse Treatment.24(4): 305-311.

Booth RE, Corsi KF, Mikulich SK. (2003). Free treatment and treatment entry among out-of-treatment injection drug users. Strategies to Improve the Replicability, Sustainability, and Durability of HIV Prevention Interventions for Drug Users, National Institute on Drug Abuse,

Booth RE, Kennedy JK, Brewster JT, Semerik O. (2003). Drug injectors and dealers in Odessa, Ukraine. Journal of Psychoactive Drugs, 35: 419-426.

Crowley TJ, Mikulich SK, Ehlers K, Hall S, Whitmore EA. (2003). Discriminative validity and clinical utility of an abuse-neglect interview for adolescents with conduct and substance use problems. The American Journal of Psychiatry.160: 1461-1469.

Freed CR, Leehey MA, Zawada M, Bjugstad K, Thompson L, Breeze RE. (2003). Do patients with Parkinson’s disease benefit from embryonic dopamine cell transplantation? Journal of Neurology, 250, III/44-III/46.

Hopfer CJ, Crowley TJ, Hewitt JK. (2003). Review of twin and adoption studies of adolescent substance use. Journal of the American Academy of Child and Adolescent Psychiatry, 42(6): 710-719.

Hopfer CJ, Khuri E, Crowley TJ. (2003). Treating adolescent heroin use. Journal of the American Academy of Child and Adolescent Psychiatry, 42(5): 609-611.

Hopfer CJ, Stallings MC, Hewitt JK, Crowley TJ. (2003). Family transmission of marijuana use, abuse, and dependence. Journal of the American Academy of Child and Adolescent Psychiatry,42(7): 834-841.

Kwaitkowski CF, Booth RE. (2003). HIV Risk Behaviors Among Older American Drug Users. Journal of the Acquired Immune Deficiency Syndromes. 33: S131-S138.

Loo SK, Specter E, Smolen A, Hopfer CJ, Teale PD, Reite ML. (2003). Functional effects of the DAT1 polymorphism on EEG measures in ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 42: 986-993.

Mikulich SK, Zerbe GO, Jones RH, Crowley TJ. (2003). Comparing linear and nonlinear mixed model approaches to cosinor analysis. Statistics in Medicine, 22(20): 3195-3211.

Rhee RH, Hewitt JK, Young SE, Corley RP, Crowley TJ, Stallings MC. (2003). Genetic and environmental influences on substance initiation, use, and problem use adolescents. Archives of General Psychiatry. 60(12): 1256-1264.

Riggs PD. (2003). Treating Adolescents for Substance Use and Comorbid Psychiatric Disorders. Science & Practice Perspectives. NIH Publication. 2(1): 18-29.

Stallings MC, Corley RP, Hewitt JK, Krauter KS, Lessem JM, Mikulich SK, Rhee S, Smolen A, Young SE, Crowley TJ. (2003). A genome-wide search for quantitative trait loci influencing substance dependence vulnerability in adolescence. Drug and Alcohol Dependence70(3): 295-307.

2002
Corsi KF, Kwiatkowski CF, Booth RE. (2002). Predictors of positive outcomes for out-of-treatment opiate injectors recruited into methadone maintenance through street outreach. Journal of Drug Issues, 999-1016.

Dubovsky S, Davies R, Dubovsky A (2002). Mood disorders. In: Hales RE, Yudofsky SC, Talbott JA (ed). American Psychiatric Press Textbook of Psychiatry, Fourth Edition. American Psychiatric Press, Washington, DC.

Hopfer CJ, Khuri E, Crowley TJ, Hooks S. (2002). Adolescent heroine use: A review of the descriptive and treatment literature. Journal of Substance Abuse Treatment,23: 231-237.

Kwiatkowski CF, Corsi KF, Booth RE. (2002). The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users. Addiction, 97: 1289-1294.

Kwiatkowski DF, Fortuin Corsi K, Booth RE. (2002). The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users. Addiction, 97, 129-1294.

Reich W, Compton W, Horton J, Cottler L, Cunningham-Williams R, Booth RE, Singer M, Leukefeld C, Fink J, Stopka, T, Fortuin CK, Staton TM, (2002). Pharmacist ambivalence about over-the-counter sale of syringes to injection drug users. Journal of the American Pharmaceutical Association.42: S52-S57.

Reich W, Compton W, Horton J, Cottler L, Cunningham-Williams R, Booth R, Singer M, Leukefeld C, Fink J, Stopka T, Fortuin Corsi K, Staton Tindall M. (2002). Injection drug users report good access to pharmacy sale of syringes. Journal of the American Pharmaceutical Association, 42: S68-S72.

Riggs PD, Davies RD. (2002). A Clinical Approach to Integrating Treatment for Adolescent Depression and Substance Abuse. Journal of the American Academy of Child and Adolescent Psychiatry, 41(10): 1253-1255.

Ross RG, Olincy A, Mikulich SK, Radant AD, Harris JG, Waldo M, Compagnon N, Heinlein S, Leonard S, Zerbe GO, Adler L, Freedman R. (2002). Admixture analysis of smooth pursuit eye movements in probands with schizophrenia and their relatives suggests gain and leading saccades are potential endophenotypes. Psychophysiology, 39(6): 809-819.

Thompson, L.L. (2002). Ethical issues in interpreting and explaining assessment results. In S. Bush & M. Drexler (Eds.), Ethical Issues in Clinical Neuropsychology, (pp 51-72). Lisse, Netherlands: Swets & Zeitlinger.

Young SE, Corley RP, Stallings MC, Rhee SH, Crowley TJ, Hewitt JK. (2002). Substance use, abuse and dependence in adolescents: Prevalence, symptom profiles and correlates. Drug and Alcohol Dependence, 68(3): 309-322.

2001
Amass L, Kamien JB, Mikulich SK. (2001). Thrice-weekly supervised dosing with the combination buprenorphine-naloxone tablet is preferred to daily supervised dosing by opioid-dependent humans. Drug and Alcohol Dependence, 61: 173-181.

Crowley TJ, Mikulich SK, Ehlers KM, Whitmore EA, Macdonald MJ. (2001). Validity of structured clinical evaluations in adolescents with conduct and substance problems. Journal of the American Academy of Child and Adolescent Psychiatry, 40(3): 265-273.

Davies RD, Gabbert SL, Riggs PD. (2001). Anxiety disorders in neurologic illness. Current Treatment Options in Neurology, 3(4): 333-346.

Freed CR, Clarkson ED, Leehey MA, Zawada M, Thompson LL, Breeze RE. (2001). Clinical experience with fetal neural transplantation in Parkinson’s disease. In J.K. Krauss, J. Jankovic & R.G. Grossman (Eds.), Surgery for Parkinson’s Disease and Movement Disorders (pp 210-216). Philadelphia: Lippincott Williams and Wilkins.

Hopfer CJ, Hewitt JK, Stallings MC. (2001). Common genetic and environmental vulnerability for alcohol and tobacco use in a volunteer sample of older female twins. Journal of Studies on Alcohol, 62: 717-723.

John D, Kwiatkowski CF, Booth RE. (2001). Differences among out-of-treatment drug injectors who use stimulants only, opiates only or both: implications for treatment entry. Drug and Alcohol Dependence, 64: 165-173.

Kwiatkowski CF, Booth RE. (2001). Methadone maintenance as HIV risk reduction with street-recruited injecting drug users. Journal of Acquired Immune Deficiency Syndromes,  26: 483-489.

Mikulich SK, Hall SK, Whitmore EA, Crowley TJ. (2001). Concordance between DSM-III-R and DSM-IV diagnosis of substance use disorders in adolescents. Drug and Alcohol Dependence, 61: 237-248.

Ramig LO, Sapir S, Countryman S, Pawlas AA, O’Brien C, Hoehn MM. Thompson LL. (2001). Intensive voice treatment (LSVT) for individuals with Parkinson’s disease: a 2 year follow-up. Journal of Neurology, Neurosurgery and Psychiatry, 71: 493-498.

Sapir S, Pawlas AA, Ramig LO, Countryman S, O’Brien C, Hoehn MM, Thompson LL. (2001). Voice and speech abnormalities in Parkinson disease: Relation to severity of motor impairment, duration of disease, medication, depression, gender, and age. Journal of Medical Speech-Language Pathology, 9: 213-226.

Thompson LL. (2001). Easy access to the best norms: A daunting task. Review of Handbook of Normative Data for Neuropsychological Assessment by M.N. Marushina, K.B. Boone, & L.F. D’Elia. Contemporary Psychology, 46: 318-319.

2000
Amass L, Kamien JB, Mikulich SK. (2000). Efficacy of daily and alternate-day dosing regimens with the combination buprenorphine-naloxone tablet. Drug and Alcohol Dependence, 58: 143-152.

Booth RE, Kwiatkowski CF, Chitwood DD. (2000). Sex-related HIV risk behaviors: differential risks among injection drug users, crack smokers, and injection drug users who smoke crack. Drug and Alcohol Dependence, 58: 219-226.

Davies RD, Dubovsky SL, Gabbert S, Chapman M (2000). Treatment resistance in anxiety disorders. Bulletin of the Menninger Clinic 64(3A): A22-A36.

Davies RD, Winter L. (2000). Generalized anxiety disorder In: J. Jacobson, M.D. and A. Jacobson, M.D. (ed). Psychiatric Secrets, 2nd Edition.

Davies RD. (2000). Social phobias and specific phobias. In: J. Jacobson, M.D. and A. Jacobson, M.D. (ed). Psychiatric Secrets, 2nd Edition.

Davies RD. (2000). Panic attacks and panic disorder In: J. Jacobson, M.D. and A. Jacobson, M.D. (ed). Psychiatric Secrets, 2nd Edition.

Davies RD, Winter L. (2000). Antianxiety agents. In: J. Jacobson, M.D. and A. Jacobson, M.D. (ed). Psychiatric Secrets, 2nd Edition.

Deas D, Riggs PD, Goldman M, Langdenbucher J, Brown S. (2000).Adolescents are not adults. Developmental considerations in adolescent alcohol use. Alcoholism: Clinical and Experimental Research, 24(2): 232-237.

Grissom CK, Radwin MI, Harmston CH, Hirshberg EL, Crowley TJ. (2000). Respiration during snow burial using an artificial air pocket. Journal of the American Medical Association, 283(17): 2266-2271.

Fortuin K, Kwiatkowski C, Brewster T, Ennis E, Crowley T, Booth R. (2000). Can you ever have enough treatment? NIDA Research Monographs, 181.

Hopfer CJ, Mikulich SK, Crowley TJ. (2000). Heroin use among adolescents in treatment for substance use disorders. J Am Acad Child Adolesc Psychiatry 39(10): 1316-1323.

Hopfer CJ, Whitmore EA, Riggs PD, Swafford WB, Crowley TJ. (2000). Diagnosis and management of substance use disorders in young adulthood. Primary Care Case Reviews, 3(4): 172-181.

Johnson ME, Fisher DG, Montoya I, Booth RE, et al. (2000). Reliability and validity of follow-up data from drug users not in treatment. AIDS and Behavior. 4: 373-380.

Kongs SK, Thompson LL, Iverson GL, Heaton RK. (2000). Wisconsin Card Sorting Test - 64 Card Version Professional Manual. Odessa, FL: Psychological Assessment Resources.

Kwaitkowski CF, Booth RE. (2000). Differences in HIV risk behaviors among women who exchange sex for drugs, money or both drugs and money. AIDS and Behavior, 4: 233-240.

Kwiatkowski CF, Booth RE, Lloyd LL. (2000). The effects of offering free treatment to street-recruited injection opiate users. Addiction, 95: 697-704.

Slade J, Bickel WK, Crowley TJ, Ferrence R, Henningfield JE, Houston TP, Mitchell B, Room R, Sweanor D, Warner KE. (2000). The role of managing nicotine in controlling the tobacco epidemic. In Ferrence R, Slade J, Room R, Pope M (eds.), Nicotine and Public Health(pp. 483-501). Washington, D.C.: American Public Health Association.

1999
Benson JA Jr, Watson SJ Jr, Childers SR, Crout JR, Crowley TJ, Feinberg J, Fields HL, Hatsukami D, Larson EB, Martin BR, Vollmer TL. (1999). Marijuana and medicine: Assessing the science base. Institute of Medicine. Washington, D.C.: National Academy Press.

Booth RE, Kwiatkowski CF. (1999). Substance abuse treatment for high-risk adolescents. Current Psychiatry Reports.1: 185-190.

Booth RE, Kwiatkowski CF, Weissman G. (1999). Health-related service utilization and HIV risk behaviors among HIV infected injection drug users and crack smokers. Drug and Alcohol Dependence. 55: 69-78.

Booth RE, Zhang Y, Kwiatkowski CF. (1999). The challenge of changing drug and sex risk behaviors of runaway and homeless adolescents. Child Abuse & Neglect, 23: 1295-1306.

Crowley TJ. (1999). Research on contingency management treatment of drug dependence: Clinical implications and future directions. In S.T. Higgins & K. Silverman (eds.), Motivating behavior change among illicit-drug abusers: Research on contingency management interventions (pp. 345-370). Washington, D.C.: American Psychological Association.

Cullum CM, Thompson LL. (1999). Evaluation of neuropsychological status following mild traumatic brain injury. In M.J. Raymond, T.L. Bennett, L.C. Hartlage, & C.M. Cullum (eds.). Mild Traumatic Brain Injury: A clinician’s guide (pp. 31-47). Austin, TX: Pro-ed.

Filley CM, Thompson LL, Sze C-I, Simon JA, Paskavitz JF, Kleinschmidt-DeMasters BK. (1999). White matter dementia in CADASIL. Journal of the Neurological Sciences, 163: 163-167.

Mikulich SK, Zerbe GO, Jones RH, Crowley TJ. (1999). Relating the classical covariance adjustment techniques of multivariate growth curve models to modern univariate mixed effects models. Biometrics, 55: 957-964.

Riggs PD, Mikulich SK, Whitmore EA, Crowley TJ. (1999). Relationship of ADHD, depression, and non-tobacco substance use disorders to nicotine dependence in substance-dependent delinquents. Drug and Alcohol Dependence, 54: 195-205.